Shu Lu

1.3k total citations
9 papers, 74 citations indexed

About

Shu Lu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shu Lu has authored 9 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shu Lu's work include Coronary Interventions and Diagnostics (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Myocardial Infarction Research (2 papers). Shu Lu is often cited by papers focused on Coronary Interventions and Diagnostics (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Myocardial Infarction Research (2 papers). Shu Lu collaborates with scholars based in China and United States. Shu Lu's co-authors include Wei Su, Hongjun Zhu, Junjie Zhang, Dayang Chai, Xiangquan Kong, Hao Chen, Shao‐Liang Chen, Zhen Ge, Xiaofei Gao and Qihua Li and has published in prestigious journals such as Catheterization and Cardiovascular Interventions, Cardiovascular Drugs and Therapy and Annals of Translational Medicine.

In The Last Decade

Shu Lu

9 papers receiving 73 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Lu China 6 33 27 22 17 8 9 74
Ye Gu China 7 62 1.9× 9 0.3× 23 1.0× 21 1.2× 7 0.9× 12 94
Torstein Valborgland Norway 6 58 1.8× 38 1.4× 11 0.5× 14 0.8× 4 0.5× 10 88
Yu Hua China 5 46 1.4× 10 0.4× 15 0.7× 4 0.2× 7 0.9× 16 79
E. Hardin United States 6 55 1.7× 10 0.4× 23 1.0× 5 0.3× 23 2.9× 17 116
María Tamargo Spain 6 160 4.8× 11 0.4× 33 1.5× 15 0.9× 17 2.1× 14 180
Kerolos Wagdy Egypt 6 53 1.6× 7 0.3× 21 1.0× 11 0.6× 13 1.6× 14 77
Zhu Manlu China 2 51 1.5× 6 0.2× 13 0.6× 9 0.5× 8 1.0× 2 117
Adriana Acosta Argentina 5 43 1.3× 11 0.4× 16 0.7× 9 0.5× 9 1.1× 23 80
К. В. Протасов Russia 4 47 1.4× 3 0.1× 15 0.7× 9 0.5× 4 0.5× 45 62
Loredana Sutera Italy 6 88 2.7× 6 0.2× 24 1.1× 19 1.1× 4 0.5× 11 111

Countries citing papers authored by Shu Lu

Since Specialization
Citations

This map shows the geographic impact of Shu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Lu more than expected).

Fields of papers citing papers by Shu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Lu. The network helps show where Shu Lu may publish in the future.

Co-authorship network of co-authors of Shu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Lu. A scholar is included among the top collaborators of Shu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Lu. Shu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhou, Jing, et al.. (2022). Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study. Clinical and Applied Thrombosis/Hemostasis. 28. 2985289392–2985289392. 3 indexed citations
2.
Chen, Lianglong, Xiaofei Gao, Jing Kan, et al.. (2020). Overlapping Drug-Eluting Stent Is Associated with Increased Definite Stent Thrombosis and Revascularization: Results from 15,561 Patients in the AUTHENTIC Study. Cardiovascular Drugs and Therapy. 35(2). 331–341. 3 indexed citations
3.
Chai, Dayang, Xiangquan Kong, Shu Lu, & Junjie Zhang. (2020). CD4+/CD8+ ratio positively correlates with coronary plaque instability in unstable angina pectoris patients but fails to predict major adverse cardiovascular events. Therapeutic Advances in Chronic Disease. 11. 1754213796–1754213796. 9 indexed citations
4.
Su, Wei, et al.. (2019). Acupuncture therapy for essential hypertension: a network meta-analysis. Annals of Translational Medicine. 7(12). 266–266. 23 indexed citations
5.
Zhang, Junjie, Xiaofei Gao, Zhen Ge, et al.. (2019). Impact of intravascular ultrasound‐guided drug‐eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial. Catheterization and Cardiovascular Interventions. 93(7). 1184–1193. 13 indexed citations
7.
Yang, Qiaoning, Jingmin Zhou, Li Huang, et al.. (2018). Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial. Chinese Journal of Integrative Medicine. 24(5). 336–342. 10 indexed citations
8.
Li, Lizhi, Jingmin Zhou, Jun Wang, et al.. (2014). [Effect of Kuanxiong aerosol on coronary heart disease angina patients: a multicenter randomized controlled clinical study].. PubMed. 34(4). 396–401. 6 indexed citations
9.
Zhu, Hongjun, Shu Lu, & Wei Su. (2010). [Effect of liandou qingmai recipe on atherogenic indices of plasma and high-sensitivity C-reactive protein in patients with coronary heart disease].. PubMed. 30(4). 361–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026